What 265 reviewed firms reveal about Europe's VC map

EverythingVC's reviewed European VC directory contains 265 venture firms connected to the European market. We audited the complete cohort to answer a more useful question than "how many VCs are in Europe?": what does a source-reviewed discovery dataset reveal about the shape of the market, and where does public information remain too weak for a founder to make a confident approach?

The short answer is that European venture is geographically distributed but still anchored in a handful of large headquarters markets. Most firms describe themselves as early-stage investors, software and AI appear across almost every kind of mandate, and sector labels overlap heavily. The clearest information gap is not whether a firm calls itself a seed investor. It is whether founders can find a usable ticket range and enough current evidence to judge fit.

What exactly did we measure?

The unit in this analysis is an investment firm, not an individual fund, office or partner. One manager can operate several funds, invest from multiple offices and cover more than one stage. The 265 records are the firms that had passed the directory's baseline review by 13 July 2026; the count is not an estimate of every active VC manager in Europe.

Every record has an attributable source URL and a review date. Headquarters, offices, stages, sectors, mandate and ticket information are normalized from public information so firms can be compared. Those categories deliberately overlap: a firm can be both a pre-seed and Series A investor, or cover software, health and climate at the same time.

• Population: 265 reviewed firm records.
• Review cut-off: 13 July 2026.
• Coverage: Europe-focused, English-language investor discovery.
• Primary unit: the management firm, not the number of funds or deals.
• Important caveat: a missing field means we could not normalize reliable public information; it does not prove that the firm lacks that capability.

This distinction matters. Counting labels is reproducible, but it does not measure assets under management, current dry powder, investment pace, portfolio quality or the probability that a specific founder receives a term sheet.

Five findings from the full cohort

• The United Kingdom, Germany, France and the Netherlands account for 121 firms, or 45.7% of the directory.
• 241 firms, or 90.9%, carry a Seed label; stage positioning is broad rather than mutually exclusive.
• 219 firms, or 82.6%, include Software & AI in their normalized sector coverage.
• A usable public ticket range is recorded for 155 firms, or 58.5%; 110 records still lack one.
• 115 firms, or 43.4%, have more than one documented office, reinforcing why headquarters alone is a poor proxy for investment reach.

Headquarters: concentrated at the top, distributed underneath

The United Kingdom is the largest headquarters group in the cohort with 48 firms. Germany follows with 29, France with 26 and the Netherlands with 18. Together, those four markets represent 45.7% of all reviewed records. Expanding the group to the eight largest headquarters markets raises the share to 63.4%.

There are two messages in that distribution. First, Europe has clear institutional centres: almost one in five reviewed firms is headquartered in the UK. Second, the long tail is meaningful. Forty-five firms sit outside the 15 headquarters markets shown separately above, and several smaller ecosystems still support a visible group of local or regional investors.

But headquarters is an administrative fact, not an investment boundary. A London manager may have a pan-European mandate; a US-headquartered firm can maintain a staffed European investment team; and a specialist in a smaller market may invest across the continent. The dataset records headquarters and geographic mandate separately for precisely that reason.

The office audit makes the same point from another angle. Some 115 firms have more than one documented office. That 43.4% figure should not be read as a complete measure of cross-border investing - office pages are not always exhaustive - but it shows how often a single-country label understates a firm's operating footprint.

Stage labels: Seed is the centre of gravity

Stage categories are overlapping. The five main labels appear 729 times across 265 firms, an average of 2.75 stage labels per record. A firm counted under Seed can therefore also appear under Pre-Seed, Series A or Growth.

Seed's 90.9% share makes it the broadest discovery label in the directory, but also the least discriminating on its own. It can describe a first institutional cheque, participation in a larger seed round, or a strategy that begins at seed and reserves capital through later rounds. Series A also appears on almost two thirds of records, while nearly three in ten firms include Growth somewhere in their stated range.

For founders, the useful question is not simply whether a firm has a Seed tag. It is where the firm's entry point sits inside that range. A pre-revenue company raising EUR 750,000 has a different fit problem from a company raising EUR 8 million with repeatable revenue, even when both investors use "seed to Series A" language.

That is why the directory treats stage as a filter, then asks users to inspect ticket range, mandate, lead behaviour and current fund evidence. Stage labels widen a shortlist; they do not finish one.

Sector coverage: software is horizontal, specialism needs proof

Sector labels overlap even more than stages. The cohort carries 1,062 sector labels in total, or 4.01 per firm on average. Broad technology categories coexist with verticals, which means the percentages below should never be added together.

Software & AI appears on more than four in five records. That does not mean 219 firms have the same AI thesis. The category includes horizontal software investors, sector specialists that back software-enabled companies and deep-tech firms for which machine learning is one enabling technology.

Deep Tech is the second-largest category at 52.8%, followed by B2B Software at 49.4%. Health & Life Sciences and Climate & Energy also have substantial representation. The pattern reflects a taxonomy designed for discovery: it captures adjacency, but cannot by itself distinguish a dedicated specialist team from a generalist that occasionally invests in the sector.

A founder should therefore test any apparent sector match against three pieces of evidence: recent investments in comparable companies, partners with relevant decision-making responsibility, and a mandate that explicitly covers the business model or technical risk involved. A sector badge without those signals is weak evidence of fit.

The biggest practical gap is ticket transparency

The directory has a normalized public ticket range for 155 firms, or 58.5% of the cohort. The remaining 110 records - 41.5% - do not expose enough consistent information for a reliable range.

This is a material discovery problem because round stage and cheque size are not interchangeable. Two seed investors may sit at opposite ends of the market: one may write an initial EUR 250,000 cheque, while another expects to deploy several million euros and lead the round. Without a range, a founder cannot tell whether the stage match is economically plausible.

Missing ticket data should be interpreted conservatively. It can mean a manager decides case by case, that public materials are intentionally vague, or simply that the available source did not support a normalized minimum and maximum. We do not infer a number from portfolio round sizes because syndicates, follow-ons and undisclosed allocations make that shortcut unreliable.

The practical consequence is straightforward: records without ticket data need a second verification step before outreach. The firm's own investment pages, recent fund announcement, portfolio news and partner commentary are better evidence than a generic database estimate.

Source coverage is complete; profile depth is not

All 265 records have a source URL, spanning 264 unique source domains. This gives every base record an auditable starting point and avoids unsourced directory entries. It does not mean every profile is equally complete.

Only 10 firm profiles - 3.8% of the cohort - currently meet the higher standard for search indexing. That standard requires more than structured fields: visible primary-source citations, current active-fund and representative-investment evidence, an explanation of the European mandate, a useful founder-fit assessment and a recent editorial review.

This separation is deliberate. Baseline inclusion answers "is there enough evidence to list and compare this firm?" Index approval answers the harder question: "is this page sufficiently original, current and useful to stand alone in search?" Publishing hundreds of thin, near-identical profiles would increase page count without improving the research product.

The same distinction applies to this weekly brief. The numerical findings come from the complete internal cohort; the market interpretation is checked against external primary and institutional research. They should not be blended into a single claim about the whole European VC universe.

What the wider market evidence adds

The directory describes investor positioning, not capital flows. External data provides the missing market context.

The Invest Europe H1 2025 activity release reported EUR 10 billion of European venture investment, up 8% year on year and the strongest half-year performance since early 2022. The same release showed a more difficult capital cycle around it: combined private-equity and venture fundraising was down 19% against revised H1 2024 figures, while exits fell 42%. In other words, investment activity could improve while fundraising and liquidity remained constrained.

The EIF Equity Survey 2025, based on responses from 1,201 VC and mid-market PE fund managers, found renewed optimism and strong interest in European venture. It also identified persistent structural weaknesses: low institutional-investor participation, fragmented rules, small fund and ticket scale, difficult fundraising and a weak exit environment. More than half of respondents had increased, or were considering increasing, their exposure to EU venture markets, but positive intent did not remove those constraints.

The latest EIF Equity Barometer available at this review, for Q2 2026, points in the same mixed direction. Sentiment rebounded after the first-quarter setback and expectations improved, while fundraising remained difficult, exits fragile and geopolitical uncertainty material.

The European Commission's Startup and Scaleup Strategy reaches a similar policy diagnosis. Its financing priorities include a larger, more integrated European venture market and greater institutional-investor participation, alongside reduced regulatory fragmentation. Those are market-structure objectives, not evidence that any particular firm is active, but they explain why cross-border mandate and current deployment evidence matter so much in a European directory.

Taken together, the external evidence supports a cautious reading of our dataset. Europe has a wide early-stage investor base and visible sector depth, but discovery volume should not be confused with available capital at every stage. The financing environment remains uneven, especially when companies move from broad seed eligibility to larger rounds, follow-on capacity and eventual liquidity.

A better way to build a founder shortlist

The data suggests a six-step workflow that is more reliable than filtering by country and sending the same deck to every result. The European Fund Tracker can then be used to verify recent fund formation and the source behind each tracked close.

• Start with mandate, not headquarters. Confirm that the firm actually invests in the country where the company is based or plans to build.
• Use stage to narrow, then ticket to qualify. The cheque needs to make sense relative to the round and expected syndicate.
• Read sector evidence, not just sector labels. Look for relevant partners and recent investments that reflect the same business model or technical risk.
• Check lead behaviour and reserves. A participant, lead investor and multi-stage follow-on investor play different roles in a round.
• Verify current deployment. A recent fund close, first investment, portfolio addition or explicit investment announcement is stronger evidence than an undated strategy page.
• Treat missing data as a research task. Do not convert an unknown ticket or mandate into an assumption.

That process will produce a shorter list, but a better one. The directory's job is to make the first pass systematic and transparent; the founder's final pass should test current fit.

Limits and next review

This snapshot is a cross-section of the reviewed directory on 13 July 2026. It will change as new firms pass review, sources are refreshed, mandates evolve and inactive managers are corrected or removed.

The analysis has four important limits. It counts firms rather than capital or deals. It relies on normalized public disclosures, which vary in specificity. Overlapping stage and sector tags describe stated coverage rather than actual portfolio concentration. And headquarters and office fields do not measure cross-border deployment.

Future weekly updates should therefore focus on change, not repeat the same static count: newly verified firms, mandate corrections, ticket-range improvements, profiles promoted to the deeper editorial standard and evidence that a manager has begun or stopped deploying a fund.

The durable conclusion from this first cohort is not that Europe has 265 venture firms. It is that a useful European VC map must separate location from mandate, broad positioning from actionable fit, and a sourced directory record from a fully researched investor profile.